Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Biofrontera (BFRIW) over the last 6 years, with Q3 2025 value amounting to 89.84%.

  • Biofrontera's EBIT Margin fell 348000.0% to 89.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.4%, marking a year-over-year increase of 73600.0%. This contributed to the annual value of 46.11% for FY2024, which is 204400.0% up from last year.
  • Latest data reveals that Biofrontera reported EBIT Margin of 89.84% as of Q3 2025, which was down 348000.0% from 56.25% recorded in Q2 2025.
  • In the past 5 years, Biofrontera's EBIT Margin ranged from a high of 13.63% in Q4 2024 and a low of 371.6% during Q3 2021
  • Over the past 5 years, Biofrontera's median EBIT Margin value was 62.89% (recorded in 2023), while the average stood at 81.13%.
  • Per our database at Business Quant, Biofrontera's EBIT Margin tumbled by -2995200bps in 2021 and then surged by 2874000bps in 2022.
  • Quarter analysis of 5 years shows Biofrontera's EBIT Margin stood at 20.51% in 2021, then crashed by -168bps to 55.02% in 2022, then skyrocketed by 34bps to 36.48% in 2023, then surged by 63bps to 13.63% in 2024, then crashed by -559bps to 89.84% in 2025.
  • Its EBIT Margin was 89.84% in Q3 2025, compared to 56.25% in Q2 2025 and 52.95% in Q1 2025.